Authors: VONPAWEL J DEPIERRE A HANS K MORO D CLARK P GATZEMEIER U PAILLOT N SCHEITHAUER W CARMICHAEL J SANTORO A ROSS G MARANGOLO M

Citation: J. Vonpawel et al., TOPOTECAN (HYCAMTIN(TM)) IN SMALL-CELL LUNG-CANCER (SCLC) AFTER FAILURE OF FIRST LINE THERAPY - MULTICENTER PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1038-1038

Authors: DEPIERRE A MILLERON B MORO D QUOIX E LEBEAU B CHASTANG C BRAUN D JANICOT H PAILLOT N GOUVA S COUDERT B BRETON JL LEMARIE E LEBAS FX COETMEUR D THIBERVILLE L BREHOT JM

Citation: A. Depierre et al., PHASE-III STUDY OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLE NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1053-1053

Authors: DEPIERRE A CHASTANG C QUOIX E LEBEAU B BLANCHON F PAILLOT N LEMARIE E MILLERON B MORO D CLAVIER J HERMAN D TUCHAIS E JACOULET P BRECHOT JM CORDIER JF SOLALCELIGNY P BADRI N BESENVAL M

Citation: A. Depierre et al., VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL, Annals of oncology, 5(1), 1994, pp. 37-42

Authors: DEPIERRE A MILLERON B LEBEAU B MORO D CHASTANG C JACOULET P PAILLOT N QUOIX E JANICOT H LOMBARD JN GOUVA S BRECHOT JM LEMARIE E MIECH G BRETON JL COETMEUR D

Citation: A. Depierre et al., AN ONGOING RANDOMIZED STUDY OF NEOADJUVANT CHEMOTHERAPY IN RESECTABLENONSMALL CELL LUNG-CANCER, Seminars in oncology, 21(3), 1994, pp. 16-19